Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Darren Feldman, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
125 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Institut Jules Bordet
Anderlecht, Belgium
- University Hospital Saint Luc
Brussels, Belgium
- Rigshospitalet University Hospital
Copenhagen, Denmark
- Centre Leon Berard
Lyon, France
- Institut Paoli Calmettes
Marseille, France
- Hopital Tenon/assistance Publique - Hopitaux de Paris
Paris, France
- Chru Strasbourg - Hospital Civil
Strasbourg, France
- Center Claudius Regaud
Toulouse, France
- Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France
- Gustave Roussy
Villejuif, France
- Technical University Dresden
Dresden, Saxony, Germany
- University of Berlin Charite Campus Benjamin Franklin
Berlin, Germany
- University of Dusseldorf
Düsseldorf, Germany
- University of Essen
Essen, Germany
- University Medical Center Hamburg-Eppendorf
Hamburg, Germany
- Universitaetsklinikum Heidelberg
Heidelberg, Germany
- Gk-Mittelrhein Saint Martin'S
Koblenz, Germany
- Philipps University Marburg
Marburg, Germany
- Rotkreuzklinikum Munchen
Munich, Germany
- Klinikum Nurnberg Nord
Nuremberg, Germany
- University Hospital Ulm
Ulm, Germany
- Saint James Hospital
Dublin, Ireland
- Ospedale Di Circolo Di Busto Arsizio
Busto Arsizio, Italy
- Istituto Scientifico Romagnolo
Meldola, Italy
- Istituto Nazionale Tumori
Milan, Italy
- San Matteo Hospital
Pavia, Italy
- the Netherlands Cancer Institute
Amsterdam, Netherlands
- University Medical Center Groningen
Groningen, Netherlands
- Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands
- Duran I Reynals Hospital-Catalan Institute of Oncology
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital General Universitario Morales Meseguer
Murcia, Spain
- Inselspital
Bern, Switzerland
- Hopitaux Universitaires de Geneve
Geneva, Switzerland
- University Hospital Zurich
Zurich, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Aug 2015
- Primary completion
- 1 Jun 2031
- Completion
- 1 Jun 2031
- Last update posted
- 16 Jun 2026
- Registered enrollment
- 420
- Registry id
- NCT02375204
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.